Cipla Sustainability


Our approach to responsible resource consumption, efforts to enhance access and affordability of medicines worldwide and strong financial growth, provide a robust foundation to build a responsible business.

Sustainability Goals

By 2025

Cipla endeavours to be a Carbon Neutral, Water Neutral and Zero Waste to Landfill Company, to attain AMR Stewardship, Green Chemistry & Making it Right, Well-being of employees and partners.

By 2030

Cipla endeavours to be a Carbon Positive, Water Positive and AMR Compliant Company
8% Revenue CAGR over the last 5years
5.2% R&D Investment
₹ 21,763 Crores Revenue from Operations

Manufacturing Highlights

Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.


32.72 Billion
Tablets and capsules


144.20 Million
Aerosol pMDI


11.45 Million
Lyophilised injections


750 Million


50.60 Million
Nasal sprays


51.20 Million
Oral liquids


2.50 Million
Form-fill seal eye-drops



Learn More
Learn More